1.64
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Forecast
The Zhengye Biotechnology Holding Ltd (ZYBT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.5682, representing a -4.38% decrease from the current price of $1.64. The highest analyst price target is $2.213, and the lowest is $0.9233.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ZYBT Price Target
Average 5.7871
(+252.87% Upside)
Is Zhengye Biotechnology Holding Ltd (ZYBT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 57.17 | Neutral |
| STOCH(9,6) | 27.55 | Neutral |
| STOCHRSI(14) | 77.40 | Neutral |
| MACD(12,26) | 0.0134 | Buy |
| ADX(14) | 45.49 | Buy |
| William %R | -71.11 | Neutral |
| CCI(14) | 77.88 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.389
Buy
|
1.455
Buy
|
| MA20 |
1.3437
Buy
|
1.4194
Buy
|
| MA50 |
1.5395
Buy
|
1.4362
Buy
|
| MA100 |
1.3338
Buy
|
1.4096
Buy
|
| MA200 |
1.1402
Buy
|
1.9043
Sell
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, ZYBT could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ZYBT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 57.17 indicates that ZYBT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 27.55 indicates that ZYBT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 77.4 indicates that ZYBT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 45.49 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 77.88 indicates that ZYBT is still overbought but not to an extreme extent.
Long-term ZYBT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Zhengye Biotechnology Holding Ltd financial reports and earnings history, Zhengye Biotechnology Holding Ltd (ZYBT) stock could reach $2.6997 by 2030, $11.60 by 2040 and $20.27 by 2050. See the projected annual prices until 2050 of the Zhengye Biotechnology Holding Ltd stock below:
- Zhengye Biotechnology Holding Ltd (ZYBT) is expected to reach an average price of $3.4038 in 2035, with a high prediction of $9.5922 and a low estimate of $8.7775. This indicates an $107.55% rise from the last recorded price of $1.64.
- Zhengye Biotechnology Holding Ltd (ZYBT) stock is projected to chart a bullish course in 2040, with an average price target of $11.18, representing an $581.58% surge from its current level. The forecast ranges from a conservative $11.29 to a sky-high $11.60.
- Our analysts predict Zhengye Biotechnology Holding Ltd (ZYBT) to jump 742.13% by 2045, soaring from $19.09 to an average price of $13.81, potentially reaching $23.63. While $19.09 is the low estimate, the potential upside is significant.
- Zhengye Biotechnology Holding Ltd (ZYBT) stock is expected to climb by 2050, reaching an average of $19.25, a $1,074% jump from its current level. However, a wide range of estimates exists, with high and low targets of $20.27 and $19.32, respectively, highlighting the market's uncertainty.
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Year by Year Forecast
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2026
The predicted value for Zhengye Biotechnology Holding Ltd (ZYBT) in 2026 is set at an average of $4.3128. Estimates vary from a peak of $8.01 to a trough of $0.6155, indicating an +162.97% surge from the present price of $1.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.6528 | $0.9233 | $2.213 | +0.78% |
| December, 2026 | $1.9922 | $0.9527 | $2.0327 | +21.48% |
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Zhengye Biotechnology Holding Ltd (ZYBT) is $5.7871, with a high forecast of $11.55 and a low forecast of $0.0231. This indicates an +252.87% increase from the last price of $1.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.2516 | $0.6916 | $7.132 | -23.69% |
| February, 2027 | $10.75 | $1.0314 | $11.55 | +555.54% |
| March, 2027 | $3.2801 | $1.6356 | $11.26 | +100.01% |
| April, 2027 | $3.4195 | $1.9999 | $7.1196 | +108.50% |
| May, 2027 | $3.0787 | $2.679 | $4.2191 | +87.72% |
| June, 2027 | $4.608 | $2.338 | $8.008 | +180.98% |
| July, 2027 | $6.9374 | $4.2442 | $10.75 | +323.01% |
| August, 2027 | $0.4666 | $0.0231 | $7.2872 | -71.55% |
| September, 2027 | $0.0863 | $0.0437 | $0.5664 | -94.74% |
| October, 2027 | $0.0247 | $0.0342 | $0.3556 | -98.49% |
| November, 2027 | $0.7855 | $0.3449 | $0.7753 | -52.10% |
| December, 2027 | $1.0158 | $0.8157 | $0.8462 | -38.06% |
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2028
In 2028, Zhengye Biotechnology Holding Ltd (ZYBT) is projected to reach an average price of $3.3585, with a high projection of $6.6895 and a low estimate of $0.0274. This indicates an +104.78% rise from the last price of $1.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9727 | $1.0248 | $0.9428 | -40.69% |
| February, 2028 | $0.7983 | $0.867 | $0.7625 | -51.32% |
| March, 2028 | $0.6782 | $0.6779 | $0.6183 | -58.64% |
| April, 2028 | $0.6499 | $0.6685 | $0.6584 | -60.37% |
| May, 2028 | $0.7063 | $0.6593 | $0.629 | -56.93% |
| June, 2028 | $0.6423 | $0.6423 | $0.6798 | -60.83% |
| July, 2028 | $0.7989 | $0.0628 | $6.6895 | -51.29% |
| August, 2028 | $0.3882 | $0.3882 | $0.8887 | -76.33% |
| September, 2028 | $0.1576 | $0.0977 | $0.4081 | -90.39% |
| October, 2028 | $1.823 | $0.0274 | $1.8274 | +11.16% |
| November, 2028 | $1.3143 | $1.3343 | $1.5137 | -19.86% |
| December, 2028 | $0.8956 | $1.6653 | $1.155 | -45.39% |
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2029
The 2029 price forecast for Zhengye Biotechnology Holding Ltd Stock (ZYBT) is $4.418 on average, with a high prediction of $8.8021 and a low estimate of $0.034. This represents an +169.39% increase from the previous price of $1.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.4828 | $0.5863 | $4.8928 | +173.34% |
| February, 2029 | $4.8915 | $0.4712 | $8.8021 | +198.26% |
| March, 2029 | $0.6502 | $0.4002 | $8.4112 | -60.35% |
| April, 2029 | $0.9886 | $0.5889 | $4.5493 | -39.72% |
| May, 2029 | $0.6273 | $0.188 | $1.7083 | -61.75% |
| June, 2029 | $2.236 | $0.034 | $5.636 | +36.34% |
| July, 2029 | $2.7056 | $1.892 | $8.4154 | +64.97% |
| August, 2029 | $1.7268 | $1.7515 | $1.6264 | +5.30% |
| September, 2029 | $2.0277 | $2.0281 | $1.9292 | +23.64% |
| October, 2029 | $2.1797 | $2.0052 | $1.9798 | +32.91% |
| November, 2029 | $2.721 | $2.4601 | $2.7307 | +65.92% |
| December, 2029 | $2.7106 | $2.7313 | $2.7032 | +65.28% |
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Price Forecast for 2030
Zhengye Biotechnology Holding Ltd Stock (ZYBT) is expected to reach an average price of $3.036 in 2030, with a high forecast of $5.369 and a low forecast of $0.7029. This signifies an +85.12% surge from the last price of $1.64.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.7297 | $2.7817 | $2.6997 | +66.44% |
| February, 2030 | $2.4759 | $2.5446 | $2.46 | +50.97% |
| March, 2030 | $2.2765 | $2.3158 | $2.2555 | +38.81% |
| April, 2030 | $2.1479 | $2.1881 | $2.2368 | +30.97% |
| May, 2030 | $2.126 | $2.1186 | $2.0784 | +29.63% |
| June, 2030 | $1.9827 | $1.9827 | $2.0797 | +20.89% |
| July, 2030 | $0.4423 | $0.9823 | $5.369 | -73.03% |
| August, 2030 | $0.7735 | $0.7029 | $0.6835 | -52.83% |
| September, 2030 | $0.3951 | $0.9607 | $0.8768 | -75.91% |
| October, 2030 | $4.8696 | $0.7055 | $4.4396 | +196.92% |
| November, 2030 | $4.2815 | $4.3015 | $4.5205 | +161.07% |
| December, 2030 | $3.4989 | $3.9039 | $4.0825 | +113.35% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):